Diagnostic Electrocardiograph Market Report 2026

The diagnostic electrocardiograph market size has grown strongly in recent years. It will grow from $8.69 billion in 2025 to $9.29 billion in 2026 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to high prevalence of cardiovascular diseases, hospital-based cardiac diagnostics dominance, growth in aging population, reliance on traditional ecg systems, expansion of cardiac care units.

The diagnostic electrocardiograph market size is expected to see strong growth in the next few years. It will grow to $12.05 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to remote cardiac monitoring adoption, wearable ecg innovation, preventive cardiology focus, telecardiology expansion, demand for early arrhythmia detection. Major trends in the forecast period include growing adoption of portable and wearable ecg devices, integration of ecg systems with cloud platforms, rising use of remote cardiac monitoring, increased demand for multi-lead ecg systems, expansion of ecg use in preventive cardiology.

The rising prevalence of heart disorders worldwide is expected to drive the growth of the diagnostic electrocardiograph market in the coming years. Heart disorders include a wide range of cardiovascular conditions, such as arrhythmias, heart attacks, congenital heart defects, and heart failure. The growing incidence of these conditions is linked to factors including aging populations, sedentary lifestyles, and unhealthy dietary habits, which contribute to higher rates of obesity and hypertension, both major risk factors for cardiovascular disease. Diagnostic electrocardiography plays a vital role in addressing the increasing burden of heart disorders by enabling early detection, continuous monitoring, and effective management of cardiac conditions through non-invasive assessment of the heart’s electrical activity. For instance, in January 2024, according to the American Heart Association, a US-based nonprofit organization, cardiovascular-related deaths increased slightly to 931,578, representing an increase of about 3,000 deaths compared to the previous year’s total of 928,741. Therefore, the growing prevalence of heart disorders is fueling the expansion of the diagnostic electrocardiograph market.

Major companies operating in the diagnostic electrocardiograph market are increasingly focusing on advanced technologies, such as artificial intelligence-powered ECG systems, to improve diagnostic accuracy and operational efficiency in cardiovascular care. AI-integrated ECG systems enhance the interpretation of cardiac electrical signals, supporting faster and more precise diagnosis. For instance, in June 2024, AliveCor, a US-based medical technology company, introduced its KAI 12L AI technology in conjunction with the Kardia 12L ECG System. This innovation represents the world’s first AI-enabled handheld 12-lead ECG system capable of detecting critical cardiac conditions, including heart attacks, using a simplified lead configuration. The system features a distinctive single-cable design and leverages patented technology to advance point-of-care cardiac diagnostics.

In July 2023, Inuvi Health Ltd., a UK-based provider of domiciliary health assessments and nationwide phlebotomy services, acquired Express Diagnostics for an undisclosed amount. Through this acquisition, Inuvi Health expanded its diagnostic capabilities and strengthened its service portfolio, allowing it to offer a broader range of diagnostic solutions and reach a wider customer base. Express Diagnostics is a UK-based company specializing in the development and manufacturing of diagnostic testing solutions, including electrocardiograph devices.

Major companies operating in the diagnostic electrocardiograph market are Koninklijke Philips N.V., GE Healthcare Inc., Suzuken Company Limited, Mindray Medical International Limited, Nihon Kohden Corporation, OSI Systems Inc., Fukuda Denshi Co. Ltd., Midmark Corporation, BTL Group of Companies, BioTelemetry Inc., Spacelabs Healthcare Inc., Welch Allyn Inc., Schiller AG, CardioNet Inc., VectraCor Inc., BPL Limited, SunTech Medical Inc., Mortara Instrument Inc., Allengers Medical Systems Limited, Bionet Co. Ltd., ScottCare Corporation, Nasiff Associates Inc., Compumed Inc., Norav Medical.

North America was the largest region in the diagnostic electrocardiograph market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the diagnostic electrocardiograph market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the diagnostic electrocardiograph market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the diagnostic electrocardiograph market by increasing costs of imported electronic components, sensors, display units, and monitoring hardware. Hospitals and cardiac centers in North America and Europe are most affected due to reliance on imported ECG equipment, while Asia-Pacific faces higher device procurement costs. These tariffs increase system prices. However, they also encourage local manufacturing and regional assembly of ECG devices.

The diagnostic electrocardiograph market research report is one of a series of new reports that provides diagnostic electrocardiograph market statistics, including diagnostic electrocardiograph industry global market size, regional shares, competitors with a diagnostic electrocardiograph market share, detailed diagnostic electrocardiograph market segments, market trends and opportunities, and any further data you may need to thrive in the diagnostic electrocardiograph industry. This diagnostic electrocardiograph market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A diagnostic electrocardiograph (ECG or EKG) is a medical device used to record the electrical activity of the heart over a specific period. It captures the electrical impulses produced by cardiac muscle depolarization and converts them into a visual electrocardiogram, displayed either on paper or digitally on a screen. Diagnostic ECGs are essential tools in cardiology for evaluating heart function, diagnosing conditions such as arrhythmias, ischemia, and myocardial infarction, and monitoring the effectiveness of cardiac treatments.

The main product and service types in diagnostic electrocardiography include resting electrocardiogram devices, stress electrocardiogram devices, Holter monitors, implantable loop recorders, event monitors, mobile cardiac telemetry (MCT) devices, and smart electrocardiogram monitors. Resting ECG devices measure the heart’s electrical activity while the patient is at rest and are used to detect abnormalities in heart rhythm, heart attacks, and other cardiac conditions. Lead types include 12-lead, 5-lead, and 3-lead configurations, among others. These devices are utilized by hospitals, clinics, cardiac centers, ambulatory surgical centers, and other healthcare settings.

The diagnostic electrocardiograph market consists of revenues earned by entities providing services such as installation, maintenance, calibration, training, and consulting. The market value includes the value of related goods sold by the service provider or included within the service offering. The diagnostic electrocardiograph market also includes sales of ECG electrodes, software for ECG analysis, telemetry systems, ambulatory ECG systems, ECG cables, and leads. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.